Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$362,934,695
-$41,212,458 QoQ
Shares Held
6,923,642
-5.5% QoQ
Ownership
0.346%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#9
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. GSK ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $362,934,695 | 6,923,642 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $404,147,153 | 7,322,833 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $387,151,387 | 7,894,729 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $343,208,837 | 7,952,012 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $308,981,452 | 8,046,392 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $299,162,443 | 7,722,314 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $255,913,301 | 7,566,922 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $307,899,492 | 7,531,788 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $393,942,625 | 10,232,276 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $491,522,254 | 11,465,413 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $475,070,582 | 12,818,958 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $462,797,406 | 12,766,825 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $464,464,792 | 13,032,121 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $437,381,844 | 12,292,913 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $408,309,018 | 11,619,494 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $329,160,364 | 11,184,518 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $633,740,978 | 14,843,717 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $648,860,191 | 15,187,378 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $653,998,201 | 15,120,199 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $553,830,188 | 14,778,118 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $572,889,447 | 14,668,615 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $544,088,696 | 15,543,281 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $597,422,841 | 16,552,117 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $653,002,902 | 17,688,257 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $705,057,723 | 17,623,433 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $637,917,819 | 17,165,627 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||